广州安必平医药科技股份有限公司关于自愿披露公司及子公司2025年7-9月获得资质情况的公告

Core Points - The company and its subsidiaries obtained 36 domestic medical device registration/filing certificates, 6 intellectual property qualifications, and 6 overseas certifications between July and September 2025 [1] Group 1: Domestic Medical Device Registration - The company received 36 domestic medical device registration/filing certificates, enhancing its product offerings in the medical device sector [1] Group 2: Intellectual Property Qualifications - The company secured 6 intellectual property qualifications, which include patent certificates and computer software copyright registration certificates, contributing to a stronger intellectual property protection system [1] Group 3: Overseas Certifications - The company obtained 6 overseas certifications, including CE certificates, which will facilitate the expansion of its products into international markets [1] Group 4: Impact on the Company - The acquisition of these qualifications is expected to enrich the company's product variety, improve its intellectual property protection framework, expand its product layout in tumor screening and precision diagnosis, and enhance its core competitiveness in overseas applications [1]